WAM
ALXN

World Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

World Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,045
Closed -$927K – 882
2021
Q2 		$927K Sell
5,045
-126
-2% -$21.6K 0.08% 237
2021
Q1 		$872K Sell
5,171
-365
-7% -$56.5K 0.08% 256
2020
Q4 		$865K Sell
5,536
-246
-4% -$31.6K 0.08% 240
2020
Q3 		$662K Buy
5,782
+8
+0.1% +$863 0.07% 283
2020
Q2 		$648K Sell
5,774
-3,192
-36% -$339K 0.07% 271
2020
Q1 		$805K Sell
8,966
-6,026
-40% -$591K 0.07% 269
2019
Q4 		$1.62M Buy
14,992
+3
+0% +$321 0.07% 263
2019
Q3 		$1.47M Buy
14,989
+176
+1% +$19.8K 0.07% 274
2019
Q2 		$1.94M Buy
14,813
+253
+2% +$32.6K 0.1% 220
2019
Q1 		$1.97M Buy
14,560
+337
+2% +$41.9K 0.1% 209
2018
Q4 		$1.39M Sell
14,223
-432
-3% -$51.1K 0.09% 242
2018
Q3 		$2.04M Sell
14,655
-80
-0.5% -$10K 0.1% 221
2018
Q2 		$1.83M Buy
14,735
+487
+3% +$56.9K 0.09% 250
2018
Q1 		$1.59M Sell
14,248
-5,116
-26% -$612K 0.07% 316
2017
Q4 		$2.32M Sell
19,364
-1,519
-7% -$185K 0.08% 310
2017
Q3 		$2.93M Sell
20,883
-247
-1% -$33.6K 0.1% 246
2017
Q2 		$2.57M Sell
21,130
-3,067
-13% -$357K 0.09% 273
2017
Q1 		$2.93M Buy
24,197
+3,987
+20% +$514K 0.1% 256
2016
Q4 		$2.47M Sell
20,210
-1,736
-8% -$212K 0.09% 262
2016
Q3 		$2.69M Buy
21,946
+429
+2% +$55.2K 0.1% 265
2016
Q2 		$2.51M Buy
21,517
+120
+0.6% +$17K 0.1% 263
2016
Q1 		$2.98M Sell
21,397
-2,690
-11% -$395K 0.12% 211
2015
Q4 		$4.59M Buy
24,087
+956
+4% +$167K 0.17% 126
2015
Q3 		$3.62M Buy
23,131
+531
+2% +$96.9K 0.15% 158
2015
Q2 		$4.08M Sell
22,600
-190
-0.8% -$32.8K 0.16% 143
2015
Q1 		$3.95M Buy
22,790
+257
+1% +$46.5K 0.14% 169
2014
Q4 		$4.17M Sell
22,533
-4,845
-18% -$898K 0.14% 156
2014
Q3 		$4.54M Buy
27,378
+1,466
+6% +$241K 0.14% 164
2014
Q2 		$4.05M Sell
25,912
-66
-0.3% -$10.4K 0.12% 195
2014
Q1 		$3.95M Sell
25,978
-3,312
-11% -$527K 0.12% 192
2013
Q4 		$3.9M Sell
29,290
-4,788
-14% -$575K 0.11% 219
2013
Q3 		$3.96M Sell
34,078
-4,114
-11% -$451K 0.1% 244
2013
Q2 		$3.52M Buy
+38,192
New +$3.68M 0.08% 288

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

World Asset Management's ALXN Position: Q3 2021 in Review

World Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 5,045 shares — an estimated $927K sold.

World Asset Management first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $4.59M in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • World Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • World Asset Management sold 5,045 Alexion Pharmaceuticals shares in Q3 2021, an estimated $927K.
  • World Asset Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • World Asset Management's Alexion Pharmaceuticals position peaked at $4.59M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.